Cipla launches Innoventia - To invest upto 15 million dollar in disruptive healthcare idea

Published On 2018-06-05 10:07 GMT   |   Update On 2021-08-17 05:49 GMT

Hurry up!!! Last date to apply is 17th June 2018!!


If you have a groundbreaking Idea in healthcare to meet the unmet needs of patients then INNOVENTIA is the platform to give your idea a strong foundation.


Pharma company Cipla's initiative Innoventia plans to invest upto USD 15 million in a disruptive healthcare idea.


Innoventia is envisioned to crowdsource and incubate disruptive ideas in healthcare to meet the unmet needs of patients.


Cipla's Growth Challenge is a contest for everyone all around the globe. The ideas could range from pharma, diagnostics, devices, digital, and services, to any other way to help in taking Cipla's purpose of 'Caring for Life' forward. Ideas can be at any stage of ideation – from the idea stage to early revenue stage.


The most disruptive ideas will be selected by a distinguished panel consisting of prominent industry leaders. Cipla will give the winner an opportunity to elevate that idea by partnering, investing and incubating it with a USD 15 million especially allocated for this purpose, a company statement said.


The ideas could range from pharma, diagnostics, devices, digital, and services.


To submit your IDEA click on the given link below.

https://innoventia.cipla.com/

Tags:    
Article Source : With Agency Inputs

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News